Chronic NOS inhibition prevents adverse lung remodeling and pulmonary arterial hypertension in caveolin-1 knockout mice

Pulmonary Pharmacology and Therapeutics

Volumn 21, Issue 3, 2008, Pages 507-515

  Wunderlich, Carsten ^a   Schmeisser, Alexander ^a   Heerwagen, Christian ^a   Ebner, Bernd ^a   Schober, Kristin ^a   Braun Dullaeus, Ruediger C ^a   Schwencke, Carsten ^a   Kasper, Michael ^b   Morawietz, Henning ^b   Strasser, Ruth H ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b Department of Anatomy ^*  (Germany)

Author keywords

Caveolin; eNOS; Lung fibrosis; Nitric oxide; Superoxide

Indexed keywords

CAVEOLIN 1; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME INHIBITION; EXERCISE; FEMALE; HEART RIGHT VENTRICLE HYPERTROPHY; KNOCKOUT MOUSE; LUNG ARTERY PRESSURE; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; OXYGEN SATURATION; PATHOGENESIS; PERINATAL PERIOD; PHENOTYPE; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

ANIMALS; BLOOD PRESSURE; CAVEOLIN 1; ENZYME INHIBITORS; HYPERTENSION, PULMONARY; HYPERTROPHY, LEFT VENTRICULAR; LIVER; LUNG; MICE; MICE, KNOCKOUT; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; ORGAN SIZE; OXIDANTS; OXIDATIVE STRESS; PHENOTYPE; PHYSICAL CONDITIONING, ANIMAL; PULMONARY ARTERY; RESPIRATORY FUNCTION TESTS; SIGNAL TRANSDUCTION; SUPEROXIDES;

EID: 43049126174     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2007.11.005     Document Type: Article

References (22)

1. Razani B., and Lisanti M.P. Caveolin-deficient mice: insights into caveolar function human disease. J Clin Invest 108 (2001) 1553-1561
2. Razani B., Engelman J.A., Wang X.B., Schubert W., Zhang X.L., Marks C.B., Macaluso F., Russell R.G., Li M., Pestell R.G., Di Vizio D., Hou Jr. H., Kneitz B., Lagaud G., Christ G.J., Edelmann W., and Lisanti M.P. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem 276 (2001) 38121-38138
3. Drab M., Verkade P., Elger M., Kasper M., Lohn M., Lauterbach B., Menne J., Lindschau C., Mende F., Luft F.C., Schedl A., Haller H., and Kurzchalia T.V. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293 (2001) 2449-2452
4. Galbiati F., Engelman J.A., Volonte D., Zhang X.L., Minetti C., Li M., Hou Jr. H., Kneitz B., Edelmann W., and Lisanti M.P. Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities. J Biol Chem 276 (2001) 21425-21433
5. Razani B., Wang X.B., Engelman J.A., Battista M., Lagaud G., Zhang X.L., Kneitz B., Hou Jr. H., Christ G.J., Edelmann W., and Lisanti M.P. Caveolin-2-deficient mice show evidence of severe pulmonary dysfunction without disruption of caveolae. Mol Cell Biol 22 (2002) 2329-2344
6. Gratton J.P., Bernatchez P., and Sessa W.C. Caveolae and caveolins in the cardiovascular system. Circ Res 94 (2004) 1408-1417
7. Murata T., Lin M.I., Huang Y., Yu J., Bauer P.M., Giordano F.J., and Sessa W.C. Reexpression of caveolin-1 in endothelium rescues the vascular, cardiac, and pulmonary defects in global caveolin-1 knockout mice. J Exp Med 204 (2007) 2373-2382
8. Jasmin J.F., Mercier I., Hnasko R., Cheung M.W., Tanowitz H.B., Dupuis J., and Lisanti M.P. Lung remodeling and pulmonary hypertension after myocardial infarction: pathogenic role of reduced caveolin expression. Cardiovasc Res 63 (2004) 747-755
9. Zhao Y.Y., Liu Y., Stan R.V., Fan L., Gu Y., Dalton N., Chu P.H., Peterson K., Ross Jr. J., and Chien K.R. Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice. Proc Natl Acad Sci USA 99 (2002) 11375-11380
10. Park D.S., Cohen A.W., Frank P.G., Razani B., Lee H., Williams T.M., Chandra M., Shirani J., de Souza A.P., Tang B., Jelicks L.A., Factor S.M., Weiss L.M., Tanowitz H.B., and Lisanti M.P. Caveolin-1 null (-/-) mice show dramatic reductions in life span. Biochemistry 42 (2003) 15124-15131
11. Mathew R., Huang J., Shah M., Patel K., Gewitz M., and Sehgal P.B. Disruption of endothelial-cell caveolin-1alpha/raft scaffolding during development of monocrotaline-induced pulmonary hypertension. Circulation 110 (2004) 1499-1506
12. Achcar R.O., Demura Y., Rai P.R., Taraseviciene-Stewart L., Kasper M., Voelkel N.F., and Cool C.D. Loss of caveolin and heme oxygenase expression in severe pulmonary hypertension. Chest 129 (2006) 696-705
13. Wunderlich C., Schober K., Lange S.A., Drab M., Braun-Dullaeus R.C., Kasper M., Schwencke C., Schmeisser A., and Strasser R.H. Disruption of caveolin-1 leads to enhanced nitrosative stress and severe systolic and diastolic heart failure. Biochem Biophys Res Commun 340 (2006) 702-708
14. Kuzkaya N., Weissmann N., Harrison D.G., and Dikalov S. Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase. J Biol Chem 278 (2003) 22546-22554
15. Xia Y., Dawson V.L., Dawson T.M., Snyder S.H., and Zweier J.L. Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci USA 93 (1996) 6770-6774
16. Szabo C., Ischiropoulos H., and Radi R. Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat Rev Drug Discov 6 (2007) 662-680
17. Humbert M., Sitbon O., and Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med 351 (2004) 1425-1436
18. Wunderlich C., Flogel U., Godecke A., Heger J., and Schrader J. Acute inhibition of myoglobin impairs contractility and energy state of iNOS-overexpressing hearts. Circ Res 92 (2003) 1352-1358
19. Yu J., Bergaya S., Murata T., Alp I.F., Bauer M.P., Lin M.I., Drab M., Kurzchalia T.V., Stan R.V., and Sessa W.C. Direct evidence for the role of caveolin-1 and caveolae in mechanotransduction and remodeling of blood vessels. J Clin Invest 116 (2006) 1284-1291
20. Brennan L.A., Steinhorn R.H., Wedgwood S., Mata-Greenwood E., Roark E.A., Russell J.A., and Black S.M. Increased superoxide generation is associated with pulmonary hypertension in fetal lambs: a role for NADPH oxidase. Circ Res 92 (2003) 683-691
21. Wedgwood S., and Black S.M. Role of reactive oxygen species in vascular remodeling associated with pulmonary hypertension. Antioxid Redox Signal 5 (2003) 759-769
22. Kamezaki F, Tasaki H, Yamashita K, Tsutsui M, Koide S, Nakata S, Tanimoto A, Okazaki M, Sasaguri Y, Adachi T, Otsuji Y. Gene transfer of extracellular superoxide dismutase ameliorates pulmonary hypertension in rats. Am J Respir Crit Care Med 2007 [Epub ahead of print].